159. Xeroderma pigmentosum Clinical trials / Disease details

Clinical trials : 10 / Drugs : 18 - (DrugBank : 5) / Drug target genes : 5 - Drug target pathways : 15

1 trial found

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04500548 (ClinicalTrials.gov)	January 28, 2021	4/8/2020	Testing the Combination of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) in Children, Adolescen ...	3CI Study: Childhood Cancer Combination Immunotherapy. Phase Ib and Expansion Study of Nivolumab Com ...	Constitutional Mismatch Repair Deficiency Syndrome;Hematopoietic and Lymphoid Cell Neoplasm;Lynch Sy ...	Procedure: Biospecimen Collection;Biological: Ipilimumab;Biological: Nivolumab	National Cancer Institute (NCI)	NULL	Recruiting	12 Months	25 Years	All	26	Phase 1	United States;Canada

First Previous1Next Last